60th ASH Annual Meeting & Exposition
1-4 December 2018 San Diego, CA visit conference website
This author has not written his bio yet.
But we are proud to say that Peggy Bickerton contributed 41 entries already.
1-4 December 2018 San Diego, CA visit conference website
13-16 November 2018 Dublin, Ireland visit conference website
1-5 June 2018 Chicago, IL visit conference website
January 19, 2018 Otsuka Signs Statement of Support for Women’s Empowerment Principles Astex Pharmaceuticals (“Astex”), an indirect subsidiary of Otsuka Holdings Co., Ltd., announces that the latter has signed the CEO Statement of Support for the Women’s Empowerment Principles (WEPs), a set of Principles focusing on corporate action to promote gender equality and women’s empowerment in […]
14-18 April 2018 Chicago, IL visit conference website
Further Milestone Payment Under Novartis Collaboration as Kisqali® (ribociclib) Receives Approval in Europe as a First-Line Treatment for HR+/HER2- locally Advanced or Metastatic Breast Cancer with an Aromatase Inhibitor – Kisqali was discovered as part of a strategic research collaboration under which Astex and Novartis Institutes for BioMedical Research (NIBR) scientists jointly developed and optimised […]
Further Milestone Payment Under Novartis Collaboration as Kisqali® (ribociclib) Receives FDA approval as a First-Line Treatment for HR+/HER2- Advanced Breast Cancer with an aromatase inhibitor Novartis drug Kisqali® (ribociclib, LEE011) receives marketing approval by the US FDA as a first-line drug for HR+/HER2- advanced breast cancer in combination with an aromatase inhibitor Astex’s scientific expertise […]
2-6 June 2017 Chicago, IL visit conference website
22-25 June 2017 Madrid, Spain visit conference website
26-30 October 2017 Philadelphia, PA visit conference website